《心血管藥理學和治療學雜志》是一本同行評審的雜志，出版了原始的人類基礎研究、原始動物研究和原始的實驗研究，具有潛在的臨床應用于心血管藥理學和治療學。實驗研究的重點是翻譯研究。該雜志還發表關于基礎研究、臨床研究、社論、評論、觀點和爭議的評論文章。選定的期刊補充也將出版。未來的重點將包括心臟保護療法、干細胞療法、再生心臟學、預防心臟病療法（風險因素管理）和抗心律失常療法。選定的期刊補充也將出版?！缎难芩幚韺W與治療學雜志》（JCPT）的每一期內容豐富的期刊都為心臟病學家、臨床藥理學家和研究人員提供了與疾病相關的新心血管藥物的臨床和實驗研究以及其他治療選擇。JCPT每年檢查和分析四次，包括：減少心肌梗死面積的藥物減少心肌重塑的藥物血管緊張素轉換酶抑制劑抗高血壓治療心律不整心房顫動β受體阻滯劑療法心源性中風心肌病心臟保護劑心肺復蘇術心血管綜合治療慢性咽峽炎慢性心臟缺血充血性心力衰竭冠狀動脈疾病冠狀動脈血運重建肝素治療高血壓病低血壓移植設備缺血性心臟病心肌梗塞經皮冠狀動脈介入治療外周動脈疾病預處理/后處理再生心臟病學干細胞治療

Journal of Cardiovascular Pharmacology and Therapeutics is a peer-reviewed journal that publishes original basic human studies, original animal studies, and original bench research with potential clinical application to cardiovascular pharmacology and therapeutics. The focus of the experimental studies is translational research. The journal also publishes review articles on basic research, clinical research, editorials, commentaries, points of view, and controversies. Selected journal supplements will also be published. Future focus will include cardioprotective therapies, stem cell therapy, regenerative cardiology, therapies for preventive cardiology (risk factor management), and antiarrhythmic therapies. Selected journal supplements will also be published.Every informative issue of Journal of Cardiovascular Pharmacology and Therapeutics (JCPT) offers cardiologists, clinical pharmacologists and researchers involved in disease relevant clinical and experimental investigations of newer cardiovascular drugs and other therapeutic options. Four times a year, JCPT examines and analyzes arenas such as:Agents that Reduce Myocardial Infarct SizeAgents that Reduce Myocardial RemodelingAngiotensin Converting Enzyme InhibitorsAntihypertensive TherapyArrhythmiasAtrial FibrillationBeta-Blocker TherapiesCardioembolic StrokeCardiomyopathyCardioprotective AgentsCardiopulmonary ResuscitationCardiovascular Combination TherapiesChronic AnginaChronic Cardiac IschemiaCongestive Heart FailureCoronary Artery DiseaseCoronary RevascularizationHeparin TherapiesHypertensionHypotensionImplantable DevicesIschemic Heart DiseaseMyocardial InfarctionPercutaneous Coronary InterventionsPeripheral Arterial DiseasePreconditioning/PostconditioningRegenerative CardiologyStem Cell Therapy